Kara et al. [59] confirmed that when the mTOR inhibitor, rapamycin and autophagy enhancers, temosirolimus were administered to animal models of mania and depression, rapamycin improved manic behaviour and termsirolimus improved depressive behaviour. The gene discussed is MTOR; the disease is depressive symptom measurement.